Healthy volunteers (n = 40) | Patients (n = 125) | AL-amyloidosis (n = 40) | DCM (n = 60) | HCM (n = 25) | |
---|---|---|---|---|---|
LAS-epi/mid (%) | −15.9 ± 2.2 | −8.7 ± 3.8* | −8.0 ± 3.4* | −8.1 ± 3.8* | −11.4 ± 3.5* |
LAS-epi/perp (%) | −16.4 ± 2.5 | −8.9 ± 4.6* | −7.8 ± 3.6* | −7.8 ± 4.0* | −13.1 ± 4.8* |
LAS-endo/mid (%) | −21.0 ± 3.6 | −14.4 ± 7.1* | −16.2 ± 6.0* | −10.1 ± 4.6* | −22.1 ± 6.1 |
LAS-endo/perp (%) | −21.1 ± 3.9 | −14.2 ± 7.1* | −16.4 ± 6.7* | −10.0 ± 4.9* | −20.9 ± 5.7 |
Mean transmural strain (%) | −19.3 ± 3.6 | −11.6 ± 4.0* | −11.6 ± 4.3* | −10.5 ± 3.7* | −14.0 ± 2.9* |